...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience.
【24h】

Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience.

机译:肿瘤患者右颈内静脉置入中心静脉口并插入导管:单中心经验。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM OF WORK: Evaluation of suitability and safety of venous port implantation with catheter insertion via the right internal jugular vein in oncology patients. PATIENTS AND METHODS: One hundred one totally implantable venous ports were placed in 100 patients with malignancies from January 1, 2003 until March 31, 2005. Catheter of venous port was preferably inserted via the right internal jugular vein. We recorded a number of successful implantations using this venous approach and the rate of complications during the procedure and follow-up. MAIN RESULTS: Ninety-seven catheters (96%) of totally implantable venous ports were inserted via the right internal jugular vein in 96 patients, and only in four cases were we not able to access this vein. We had no complications related to catheter insertion via the right internal jugular vein. Follow-up was made in all 96 patients with a total access days of 41 in 151 days (mean: 407 days). Premature catheter removal was required in six (6.2%, 0.144 per 1,000 access days) due to complications: three catheter dislocations/malfunctions (3.1%, 0.072 per 1,000 access days), one port-related sepsis, one pocket port infection, and one decubitus over port (1%, 0.024 per 1,000 access days). Six venous ports were removed after completion of the treatment at the patient's request. CONCLUSION: The placement of totally implantable venous ports with catheter insertion via the right internal jugular vein has a high success rate without any early complications. Follow-up also demonstrates a low incidence of late complications requiring port removal.
机译:工作目的:评估肿瘤患者通过右颈内静脉插入导管进行静脉端口植入的适用性和安全性。患者与方法:自2003年1月1日至2005年3月31日,在100例恶性肿瘤患者中放置了110个完全可植入的静脉端口。静脉端口导管最好通过右颈内静脉插入。我们记录了使用这种静脉方法成功植入的次数,以及手术和随访过程中的并发症发生率。主要结果:96例患者中右颈内静脉插入了97个导管(96%),完全植入性静脉端口插入,只有4例我们无法通过该静脉。我们没有与通过右颈内静脉插入导管相关的并发症。对所有96例患者进行了随访,总访问天数为151天(41天,平均407天)。由于并发症,有六次(6.2%,每1,000个访问日,需要0.144例)需要过早拔除导管:三种导管脱位/功能失调(每1,000个访问日,有3.1%,0.072个),一个与端口相关的脓毒症,一个口袋端口感染,和一个在端口上减少(1%,每1,000访问日0.024)。治疗结束后,应患者要求移除六个静脉端口。结论:通过右颈内静脉置入完全可植入的静脉端口并插入导管具有较高的成功率,且无任何早期并发症。随访还表明,需要切除端口的晚期并发症发生率低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号